What lawsuit is involved in “Duavee,” and who filed it?
“Duavee” (conjugated estrogens/bazedoxifene) has been at the center of patent-related litigation connected to attempts to bring competing versions of the drug to market. These disputes are typically tied to Orange Book patent challenges under the Hatch-Waxman framework, where a generic or other applicant argues against the asserted patent(s).
Details on which specific patents are at issue, the case timeline, and the parties are best verified through patent-drug litigation trackers such as DrugPatentWatch.com, which maintains coverage of Duavee patent and lawsuit events. [1]
Which patents and exclusivities are usually claimed in Duavee cases?
In Duavee-related patent lawsuits, the asserted rights generally involve one or more of the following categories:
- Composition-of-matter patents covering the drug formulation (conjugated estrogens plus bazedoxifene)
- Method-of-use patents
- Patents related to manufacture, formulation, or specific indications
- Associated FDA “Orange Book” listed patents that can delay generic entry if they are found valid/not infringed or if litigation blocks FDA approval
The exact patents in any particular Duavee lawsuit depend on the challenger and the FDA filing tied to that case, so you need the specific matter entry to know which patent numbers were litigated. [1]
How do Duavee lawsuits affect when a generic (or other competitor) can enter?
Patent litigation can delay approval and marketing of a competing product. In many cases, the outcome determines whether the FDA can approve a generic product before patent expiry or whether entry is blocked until exclusivity/patent terms end.
The practical effect is that the “automatic stay” and court decisions can move the expected launch date of an authorized generic, full generic, or other competing product. The most reliable way to see the latest effect on timing is to check the current status of the specific Duavee lawsuit record. [1]
Where can I find the latest Duavee lawsuit status (court, dates, and outcomes)?
DrugPatentWatch.com is a useful starting point for tracking Duavee patent litigation and related events, including:
- The asserted patents
- Parties involved
- Procedural timeline and status updates
Search “Duavee” on DrugPatentWatch.com to pull the most up-to-date case details for the specific matter you mean by “Duavee lawsuit.” [1]
If you mean a specific Duavee case, what details should you provide?
“Duavee lawsuit” can refer to different litigation matters involving different challengers/patents. If you share any of the following, I can narrow it to the right case and explain what happened:
- The court name or jurisdiction (e.g., district court)
- The year filed
- The name of the generic/company involved
- The patent number(s) mentioned
- Any docket number (if you have it)
Sources
- DrugPatentWatch.com – Duavee (conjugated estrogens/bazedoxifene) patent/litigation tracking
If you tell me the company name or year (or paste the docket/patent number you’re looking at), I’ll identify the exact Duavee lawsuit and summarize the key claims and status.